valrubicin 40 MG/ML Intravesical Solution [Valstar]
- RxCUI
- 262063
- RxNorm name
- valrubicin 40 MG/ML Intravesical Solution [Valstar]
- Display name
- valrubicin 40 MG/ML Intravesical Solution [Valstar]
- Full name
- valrubicin 40 MG/ML Intravesical Solution [Valstar]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valstar | VALRUBICIN | Endo USA, Inc. | e96f30a0-6662-11de-8f80-0002a5d5c51b | 2024-10-31 | Warnings, Adverse reactions | 262063 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e96f30a0-6662-11de-8f80-0002a5d5c51b | VALSTAR 200 MG in 5 ML (40 MG/ML) Intravesical Solution [PSN] · valrubicin 40 MG/ML Intravesical Solution [Valstar] [SBD] · Valstar 200 MG per 5 ML Intravesical Solution [SY] | 3 | 38 | These highlights do not include all the information needed to use VALSTAR safely and effectively. See full prescribing information for VALSTAR. VALSTAR ® (valrubicin) solution, for intravesical use Initial U.S. Approval: 1981 | 20241031 |